|
ULBP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.275400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.709590E-01 |
| Normal-vs-Stage2 |
2.540200E-02 |
| Normal-vs-Stage3 |
5.407400E-01 |
| Normal-vs-Stage4 |
1.402450E-01 |
| Stage1-vs-Stage2 |
1.934430E-01 |
| Stage1-vs-Stage3 |
6.639800E-02 |
| Stage1-vs-Stage4 |
6.637100E-03 |
| Stage2-vs-Stage3 |
8.300500E-03 |
| Stage2-vs-Stage4 |
1.755580E-03 |
| Stage3-vs-Stage4 |
4.489400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.860600E-01 |
| Normal-vs-AfricanAmerican |
5.728200E-01 |
| Normal-vs-Asian |
3.315000E-01 |
| Caucasian-vs-AfricanAmerican |
3.229000E-01 |
| Caucasian-vs-Asian |
6.074600E-01 |
| AfricanAmerican-vs-Asian |
2.690600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.777400E-01 |
| Normal-vs-Female |
5.155600E-01 |
| Male-vs-Female |
4.413000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.529440E-01 |
| Normal-vs-Age(41-60Yrs) |
7.087200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.943000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.366300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.222200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.320200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.600000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.098600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.981770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.508800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.464000E-01 |
| Classical-VS-Follicular |
5.680600E-01 |
| Classical-VS-Other |
7.659000E-01 |
| Classical-VS-Normal |
2.844800E-01 |
| Tall-VS-Follicular |
9.774000E-02 |
| Tall-VS-Other |
8.141000E-01 |
| Tall-VS-Normal |
5.486200E-01 |
| Follicular-VS-Other |
6.122400E-01 |
| Follicular-VS-Normal |
1.799170E-01 |
| Other-VS-Normal |
9.399800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.036000E-01 |
| Normal-vs-N1 |
1.492800E-01 |
| N0-vs-N1 |
1.295700E-02 |
|
|
